Patent · US Active

Engineered Fc constructs

US11220531B2 · kind B2 · utility

5Cited by
12References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 5, 2018
Grant dateJan 11, 2022
Priority date—
Expiry dateJun 14, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to engineered IgG Fc constructs and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.